Home » Blog » Long-Term Efficacy Of Dupilumab In Adults With Moderate-to-Severe Atopic Dermatitis: Results From A 5-Year Open-Label Extension Trial
Long-Term Efficacy Of Dupilumab In Adults With Moderate-to-Severe Atopic Dermatitis: Results From A 5-Year Open-Label Extension Trial
4 Views
SaveSavedRemoved 0
Sufferers with moderate-to-severe atopic dermatitis (AD) usually reply inadequately to topical remedy. We assessed the long-term efficacy of dupilumab for as much as 5 years in adults with moderate-to-severe AD.
Trending Merchandise
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$25.00
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$29.71
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$32.99
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$13.99
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$17.99
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$7.85
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$8.83
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$45.40
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$9.99
Added to wishlistRemoved from wishlist 0
Carlyle Cat’s Claw Capsules 1000mg | 180 Count | Uncaria Tomentosa | Non-GMO, Gluten Free Supplement
Added to wishlistRemoved from wishlist 0
$15.28